Abbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.
Follow ABT
Abbott Laboratories (ABT) Revenue growth
Abbott Laboratories's revenue growth over the twelve months to 30 June 2026 was 8.06%, up 2.4 percentage points from fiscal 2025 (5.67%). Over the past ten years it has ranged from −8.12% (fiscal 2023) to 31.4% (fiscal 2017); the current reading is higher than 64% of that period. That is below the Medical Devices industry median of 8.80% and in line with the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 5.67% | 1.08 |
| FY2024 | 4.59% | 12.71 |
| FY2023 | −8.12% | (9.46) |
| FY2022 | 1.34% | (23.13) |
| FY2021 | 24.5% | 15.99 |
| FY2020 | 8.48% | 4.14 |
| FY2019 | 4.34% | (7.30) |
| FY2018 | 11.6% | (19.71) |
| FY2017 | 31.4% | 29.15 |
| FY2016 | 2.20% | 1.42 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 13.0% | 5.24 |
| Mar 2026 | 7.78% | 3.36 |
| Dec 2025 | 4.42% | (2.48) |
| Sep 2025 | 6.90% | (0.47) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| DXCM DexCom, Inc. compare | 15.5% |
| EW Edwards Lifesciences Corporation compare | 14.6% |
| BSX Boston Scientific Corporation compare | 13.5% |
| MDT Medtronic PLC compare | 9.77% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| SYK Stryker Corporation compare | 8.48% |
| STE STERIS plc compare | 8.37% |
| ABT Abbott Laboratories | 8.06% |
| GEHC GE HealthCare Technologies Inc. compare | 6.51% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement